Marker successfully deployed
Marker deployment in a chicken breast phantom*
*Nicolae, Alexandru, et al. “Evaluation of a ferromagnetic marker technology for intraoperative localization of nonpalpable breast lesions.” American Journal of Roentgenology 212.4 (2019): 727-733.
Imaging in Patient
Place the MOLLI Marker when the surgical treatment path is agreed with the patient.
Superficial breast ultrasonographic image of the MOLLI Marker alongside a radioactive seed implanted in a patient.**
**Data on file at MOLLI Surgical.
The MOLLI Marker is compatible with mammographic imaging
Lateral oblique mammographic image of the MOLLI Marker and the radioactive seed implanted in a patient.*
*Dr. Nicole Look Hong, Dr. Frances Wright, Mark Semple, MA Sc; Alexandru Nicolae, MSc; Ananth Ravi, PhD; University of Toronto and Sunnybrook Hospital Odette Cancer Centre. Results of a Phase I, Prospective, Non-randomized Study Evaluating a Magnetic Occult Lesion Instrument (MOLLI) for Excision of Non-palpable Breast Lesions. Poster presented at the 2019 American Society of Breast Surgeons annual meeting, Dallas, Texas. Download the PDF
The MOLLI Marker is Magnetic Resonance (MR) conditional
The MOLLI Marker is intended to be placed percutaneously in soft tissue to temporarily mark a surgical site intended for surgical removal.
A patient with an implanted MOLLI Marker can be imaged using a 1.5 T or 3.0 T MR system.
Evidence-based use of MRI in breast cancer
MRI for breast cancer screening, diagnosis, and treatment
- MRI screening indicated for BRCA mutation or at high risk of breast cancer.
- Preoperative MR imaging does not improve surgical outcomes.
- MRI indicated to monitor response during neoadjuvant chemotherapy.